Skip to main content
Log in

Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Background

Obstructive sleep apnea syndrome (OSAS) is a complex disease with a strong genetic basis. One of the primary molecular domains affected by OSAS is sympathetic activity. Neuropeptide S (NPS) plays an important role in the regulation of the sleep–wakefulness cycle, anxiety states, and daytime sleepiness. It is important to study neuropeptides related to sympathetic activity regulation and how their function could be modified by genetic variants affecting the expression of these molecules.

Objectives

We investigated the association of the non-synonymous polymorphism rs4751440 in the NPS precursor gene with OSAS and certain variables related to OSAS (daytime sleepiness, body mass index (BMI), insulin resistance, and blood pressure). This polymorphism causes an amino acid substitution in exon 3 of the human NPS precursor gene.

Patients and methods

We included 253 OSAS patients and 70 healthy subjects. Genotyping was done by polymerase chain reaction using specific flanking primers and agarose gel electrophoresis. Daytime sleepiness, BMI, plasma levels of high-density lipoprotein, glucose, total cholesterol, insulin, triglycerides, and the homeostasis model assessment index were also determined.

Results

A similar genotypic and allelic distribution was found in OSAS patients and controls. The risk of OSAS was not associated with the rs4751440 polymorphism. There was no significant interaction between daytime sleepiness or metabolic variables and the rs4751440 polymorphism.

Conclusion

Genotypic and allelic frequency distribution of the rs4751440 polymorphism was similar in OSAS patients and controls. In this population-based study, we could not show a significant association between rs4751440 polymorphism and susceptibility to OSAS or certain phenotypes related to OSAS (daytime sleepiness, BMI, systolic blood pressure, and insulin resistance) with the exception of diastolic blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Douglas NJ, Polo O (1994) Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome. Lancet 344(8923):653–655

    Article  PubMed  CAS  Google Scholar 

  2. Young TB (2004) Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry 65(Suppl 16):12–16

    PubMed  Google Scholar 

  3. Findley LJ, Barth JT, Powers DC, Wilhoit SC, Boyd DG, Suratt PM (1986) Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia. Chest 90(5):686–690

    Article  PubMed  CAS  Google Scholar 

  4. Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, Robbins J (2000) Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 48(2):115–123

    PubMed  CAS  Google Scholar 

  5. Carrera M, Barbe F, Sauleda J, Tomas M, Gomez C, Agusti AG (1999) Patients with obstructive sleep apnea exhibit genioglossus dysfunction that is normalized after treatment with continuous positive airway pressure. Am J Respir Crit Care Med 159(6):1960–1966

    PubMed  CAS  Google Scholar 

  6. Patel SR (2005) Shared genetic risk factors for obstructive sleep apnea and obesity. J Appl Physiol 99(4):1600–1606

    Article  PubMed  CAS  Google Scholar 

  7. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98(4):437–451

    Article  PubMed  CAS  Google Scholar 

  8. de Lecea L, Sutcliffe JG (2005) The hypocretins and sleep. FEBS J 272(22):5675–5688

    Article  PubMed  Google Scholar 

  9. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365–376

    Article  PubMed  CAS  Google Scholar 

  10. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43(4):487–497

    Article  PubMed  CAS  Google Scholar 

  11. Reinscheid RK, Xu YL, Civelli O (2005) Neuropeptide S: a new player in the modulation of arousal and anxiety. Mol Interv 5(1):42–46

    Article  PubMed  CAS  Google Scholar 

  12. Xu YL, Gall CM, Jackson VR, Civelli O, Reinscheid RK (2007) Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500(1):84–102

    Article  PubMed  CAS  Google Scholar 

  13. Allen IC, Pace AJ, Jania LA, Ledford JG, Latour AM, Snouwaert JN, Bernier V, Stocco R, Therien AG, Koller BH (2006) Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease. Am J Physiol Lung Cell Mol Physiol 291(5):L1005–L1017

    Article  PubMed  CAS  Google Scholar 

  14. Kormann MS, Carr D, Klopp N, Illig T, Leupold W, Fritzsch C, Weiland SK, von Mutius E, Kabesch M (2005) G-Protein-coupled receptor polymorphisms are associated with asthma in a large German population. Am J Respir Crit Care Med 171(12):1358–1362

    Article  PubMed  Google Scholar 

  15. Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, Salmikangas P, Makela S, Rehn M, Pirskanen A, Rautanen A, Zucchelli M, Gullsten H, Leino M, Alenius H, Petays T, Haahtela T, Laitinen A, Laprise C, Hudson TJ, Laitinen LA, Kere J (2004) Characterization of a common susceptibility locus for asthma-related traits. Science 304(5668):300–304

    Article  PubMed  CAS  Google Scholar 

  16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560–2572

    Article  PubMed  CAS  Google Scholar 

  17. Redline S, Tishler PV (2000) The genetics of sleep apnea. Sleep Med Rev 4(6):583–602

    Article  PubMed  Google Scholar 

  18. Vogel F, Motulsky AG (1996) Human genetics: problems and approaches. Spinger, Berlin

    Google Scholar 

  19. Roth AL, Marzola E, Rizzi A, Arduin M, Trapella C, Corti C, Vergura R, Martinelli P, Salvadori S, Regoli D, Corsi M, Cavanni P, Calo G, Guerrini R (2006) Structure–activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. J Biol Chem 281(30):20809–20816

    Article  PubMed  CAS  Google Scholar 

  20. Bao X, Nelesen RA, Loredo JS, Dimsdale JE, Ziegler MG (2002) Blood pressure variability in obstructive sleep apnea: role of sympathetic nervous activity and effect of continuous positive airway pressure. Blood Press Monit 7(6):301–307

    Article  PubMed  Google Scholar 

  21. Fletcher EC (1997) Sympathetic activity and blood pressure in the sleep apnea syndrome. Respiration 64(Suppl 1):22–28

    Article  PubMed  Google Scholar 

  22. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK (1998) Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97(10):943–945

    PubMed  CAS  Google Scholar 

  23. Donadio V, Liguori R, Vetrugno R, Contin M, Elam M, Wallin BG, Karlsson T, Bugiardini E, Baruzzi A, Montagna P (2007) Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness. J Sleep Res 16(3):327–332

    Article  PubMed  Google Scholar 

  24. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M (2008) Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 57(10):1422–1427

    Article  PubMed  CAS  Google Scholar 

  25. Rubinsztajn R, Kumor M, Byskiniewicz K, Bielicki P, Chazan R (2005) Serum leptin concentration and sympathetic activation estimated on the adrenaline and noradrenaline serum concentration in patients with obstructive sleep apnea. Pol Arch Med Wewn 113(6):544–551

    PubMed  CAS  Google Scholar 

  26. Mediano O, Barcelo A, de la Pena M, Gozal D, Agusti A, Barbe F (2007) Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J 30(1):110–113

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the nursing staff of the sleep units of the different participating hospitals for their help during the course of the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ferran Barbé.

Additional information

Supported by: ABEMAR, SEPAR, and Fondo de Investigaciones Sanitarias (02/0334, 04/1593, 05/1059).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sánchez-de-la-Torre, M., Pierola, J., Vidal, C. et al. Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea. Sleep Breath 15, 403–408 (2011). https://doi.org/10.1007/s11325-010-0348-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-010-0348-1

Keywords

Navigation